The Use of Hematopoietic Stem Cells for Heart Failure: A Systematic Review
Open Access
- 17 June 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6634
Abstract
The purpose of this review is to summarize the current understanding of the therapeutic effect of stem cell-based therapies, including hematopoietic stem cells, for the treatment of ischemic heart damage. Following PRISMA guidelines, we conducted electronic searches in MEDLINE, and EMBASE. We screened 592 studies, and included RCTs, observational studies, and cohort studies that examined the effect of hematopoietic stem cell therapy in adult patients with heart failure. Studies that involved pediatric patients, mesenchymal stem cell therapy, and non-heart failure (HF) studies were excluded from our review. Out of the 592 studies, 7 studies met our inclusion criteria. Overall, administration of hematopoietic stem cells (via intracoronary or myocardial infarct) led to positive cardiac outcomes such as improvements in pathological left-ventricular remodeling, perfusion following acute myocardial infarction, and NYHA symptom class. Additionally, combined death, rehospitalization for heart failure, and infarction were significantly lower in patients treated with bone marrow-derived hematopoietic stem cells. Our review demonstrates that hematopoietic stem cell administration can lead to positive cardiac outcomes for HF patients. Future studies should aim to increase female representation and non-ischemic HF patients.Keywords
This publication has 35 references indexed in Scilit:
- Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of AmericaJournal of Cardiac Failure, 2023
- Stem cell-based therapy for human diseasesSignal Transduction and Targeted Therapy, 2022
- Mesenchymal Stem Cells for Cardiac Regeneration: from Differentiation to Cell DeliveryStem Cell Reviews and Reports, 2021
- Cell therapy in patients with heart failure: a comprehensive review and emerging conceptsCardiovascular Research, 2021
- The psychosocial impact of haematopoietic SCT on sibling donorsBone Marrow Transplantation, 2012
- 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the HeartJACC, 2011
- Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failureInternational Journal of Cardiology, 2010
- Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarctionJournal of Molecular and Cellular Cardiology, 2008
- Pilot study to evaluate the safety and feasibility of intracoronary CD133+ and CD133− CD34+ cell therapy in patients with nonviable anterior myocardial infarctionCatheterization and Cardiovascular Interventions, 2007
- The psychosocial aspects of donating blood stem cells: The sibling donor perspectiveJournal of Clinical Apheresis, 2003